...trial of FX-322 in 2H20. The small molecule combination therapy pairs the approved HDAC inhibitor sodium valproate...

...SciClone exclusive commercialization rights to four of its products in China. The products are Depakine sodium valproate...

...not responded well to the following drugs: carbamazepine, clobazam, gabapentin, lamotrigine , levetiracetam , oxcarbazepine, sodium valproate...

...label for Depakene sodium valproate from Kyowa Hakko Kirin to suppress the onset of migraine attacks. Depakene...
...manic disorder and bipolar disorder. Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Product: Depakene sodium valproate...

...have not responded well to the following drugs: carbamazepine, clobazam, gabapentin, lamotrigine , levetiracetam, oxcarbazepine, sodium valproate...

...have not responded well to the following drugs: carbamazepine, clobazam, gabapentin, lamotrigine , levetiracetam, oxcarbazepine, sodium valproate...

...treat partial seizures in patients ages 16 and older when converting from valproate, which includes Depakene...